🟢 Citius Pharmaceuticals is trading 5.3% up today, rebounding from post-LYMPHIR profit-taking

Citius Pharmaceuticals is trading 5.3% up at $0.60, rebounding after last week’s profit-taking drop tied to the LYMPHIR commercialization rally.

• The move appears to be a modest recovery as broader U.S. markets trade higher today.
• No fresh company-specific headlines or regulatory updates have been reported this morning beyond the prior LYMPHIR momentum.
• The stock continues to stabilize following the volatility associated with its recent commercialization news.